Medical treatment of Meniere's disease.
The aim of this article is to review the pharmacologic therapy used in the treatment of Meniere's disease. The first portion of the article discusses the treatment of acute labyrinthine crisis, which includes medication for patients that provides relief of the nausea, vomiting, and vertigo that accompanies acute attack. The second half of the article discusses medication used to help prevent attacks of Meniere's disease.
Slattery
W H
WH
Clinical Studies Department, House Ear Institute, Los Angeles, California 90057-9927, USA.
Fayad
J N
JN
D000617:Aminoglycosides; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000932:Antiemetics / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use*; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000617:Aminoglycosides; D000806:Angiotensin-Converting Enzyme Inhibitors; D000900:Anti-Bacterial Agents; D000932:Antiemetics; D002121:Calcium Channel Blockers; D004232:Diuretics; D014665:Vasodilator Agents; D001569:Benzodiazepines